Transglutaminase-positive cells in psoriatic epidermis during treatment with calcitriol (1alpha,25 dihydroxy vitamin D3) and tacalcitol (1alpha,24 dihydroxy vitamin D3)
Gerritsen
M J
MJ
van Erp
P E
PE
van de Kerkhof
P C
PC
D002117:Calcitriol / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D004817:Epidermis / Q000201:enzymology*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy / Q000201:enzymology*; D011503:Transglutaminases / Q000378:metabolism*
D003879:Dermatologic Agents; D004100:Dihydroxycholecalciferols; C023850:1 alpha,24-dihydroxyvitamin D3; D011503:Transglutaminases; D002117:Calcitriol